GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » Cyclically Adjusted PB Ratio

Willow Biosciences (Willow Biosciences) Cyclically Adjusted PB Ratio : 0.02 (As of May. 01, 2024)


View and export this data going back to . Start your Free Trial

What is Willow Biosciences Cyclically Adjusted PB Ratio?

As of today (2024-05-01), Willow Biosciences's current share price is $0.0685. Willow Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $4.14. Willow Biosciences's Cyclically Adjusted PB Ratio for today is 0.02.

The historical rank and industry rank for Willow Biosciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

CANSF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.01   Max: 0.02
Current: 0.02

During the past years, Willow Biosciences's highest Cyclically Adjusted PB Ratio was 0.02. The lowest was 0.01. And the median was 0.01.

CANSF's Cyclically Adjusted PB Ratio is ranked better than
98.63% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs CANSF: 0.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Willow Biosciences's adjusted book value per share data for the three months ended in Dec. 2023 was $0.021. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $4.14 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Willow Biosciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Willow Biosciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Cyclically Adjusted PB Ratio Chart

Willow Biosciences Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.01 0.01 0.02

Willow Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.02

Competitive Comparison of Willow Biosciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Willow Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Willow Biosciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Willow Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Willow Biosciences's Cyclically Adjusted PB Ratio falls into.



Willow Biosciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Willow Biosciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0685/4.14
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Willow Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Willow Biosciences's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.021/125.4675*125.4675
=0.021

Current CPI (Dec. 2023) = 125.4675.

Willow Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201403 31.970 98.604 40.680
201406 21.498 99.473 27.116
201409 19.072 99.394 24.075
201412 16.526 98.367 21.079
201503 13.779 99.789 17.325
201506 12.637 100.500 15.776
201509 9.985 100.421 12.475
201512 8.234 99.947 10.336
201603 9.124 101.054 11.328
201606 3.475 102.002 4.274
201609 3.965 101.765 4.889
201612 3.489 101.449 4.315
201703 2.992 102.634 3.658
201706 -1.001 103.029 -1.219
201709 -1.755 103.345 -2.131
201712 0.844 103.345 1.025
201803 0.475 105.004 0.568
201806 -0.115 105.557 -0.137
201809 0.332 105.636 0.394
201812 0.199 105.399 0.237
201903 -0.123 106.979 -0.144
201906 0.239 107.690 0.278
201909 0.237 107.611 0.276
201912 0.212 107.769 0.247
202003 0.191 107.927 0.222
202006 0.104 108.401 0.120
202009 0.035 108.164 0.041
202012 -0.005 108.559 -0.006
202103 0.148 110.298 0.168
202106 0.199 111.720 0.223
202109 0.219 112.905 0.243
202112 0.188 113.774 0.207
202203 0.174 117.646 0.186
202206 0.155 120.806 0.161
202209 0.127 120.648 0.132
202212 0.097 120.964 0.101
202303 0.070 122.702 0.072
202306 0.050 124.203 0.051
202309 0.034 125.230 0.034
202312 0.021 125.468 0.021

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Willow Biosciences  (OTCPK:CANSF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Willow Biosciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Willow Biosciences (Willow Biosciences) Business Description

Traded in Other Exchanges
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.